CFAP53 Gene Heterotaxy Visceral Type 6 NGS Genetic DNA Test
Introduction
The CFAP53 Gene Heterotaxy Visceral Type 6 NGS Genetic DNA Test is an advanced genetic test designed to identify mutations in the CFAP53 gene that are associated with heterotaxy, a condition where internal organs are arranged in an atypical manner. This test is critical for individuals with a family history of dysmorphology or those presenting symptoms related to organ placement anomalies. Understanding the genetic basis of these conditions can significantly enhance patient care and management.
What the Test Measures
This test utilizes Next Generation Sequencing (NGS) technology to detect variations in the CFAP53 gene. It provides insights into the genetic predisposition to visceral heterotaxy, which can lead to various health complications.
Who Should Consider This Test
- Individuals with a family history of heterotaxy or dysmorphology.
- Patients exhibiting symptoms such as abnormal organ positioning or congenital heart defects.
- Parents with children diagnosed with related conditions.
Benefits of Taking the Test
- Identifies genetic predispositions, allowing for proactive health management.
- Provides clarity for families regarding the risk of passing on genetic conditions.
- Facilitates informed decision-making regarding treatment and care options.
Understanding Your Results
Results from the CFAP53 Gene Heterotaxy test will indicate whether or not mutations in the CFAP53 gene are present. A genetic counseling session is recommended to help interpret these results and discuss potential implications for family members.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 400,000 NGN | 560,000 NGN |
Booking the Test
To book the CFAP53 Gene Heterotaxy Visceral Type 6 NGS Genetic DNA Test, please contact us at +2348077798758 or visit our website. Ensure you have your clinical history ready and consider scheduling a genetic counseling session for a comprehensive understanding of the test and its implications.
Turnaround time for results is approximately 3 to 4 weeks. Sample types accepted include blood, extracted DNA, or one drop of blood on an FTA card.
